Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies

Gain expert insights on the evolving role of maintenance therapy in optimizing outcomes for patients with acute myeloid leukemia in the postchemotherapy and posttransplant settings with this educational program featuring an on-demand webcast of a live roundtable discussion, downloadable slides, and an expert commentary answering key audience questions.

Share

Program Content

Activities

AML Maintenance
Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

Activities

AML Maintenance FAQs
Maintenance Strategies for AML Today: Experts Answer Frequently Asked Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 27, 2023

Activities

Critical Conversations in AML
Critical Conversations in AML: Exploring Evidence-Based Maintenance Strategies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2023

Expires: June 20, 2024

Faculty

cover img faculity

Amir T. Fathi, MD

Director, Leukemia Program
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Eytan M. Stein, MD

Chief, Leukemia Service
Director, Program for Drug Development in Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Amer Zeidan, MBBS, MHS

Associate Professor of Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale Comprehensive Cancer Center and Smilow Cancer Hospital
New Haven, Connecticut

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb